Application(s)
|
Antiprotozoal, antibacterial and amoebicidal agent
|
Application(s)
|
Treatment of susceptible anaerobic bacterial and protozoal infections in the following conditions:
|
Application(s)
|
Amebiasis, symptomatic and asymptomatic trichomoniasis; skin and skin structure infections; CNS infections; intra-abdominal infections (as part of combination regimen);
|
Application(s)
|
systemic anaerobic infections; treatment of antibiotic-associated pseudomembranous colitis (AAPC), bacterial vaginosis
|
Application(s)
|
as part of a multidrug regimen for H. pylorieradication to reduce the risk of duodenal ulcer recurrence
|
Mechanism of Action
|
After diffusing into the organism, interacts with DNA to cause a loss of helical DNA structure and strand breakage resulting in inhibition of protein synthesis and cell death in susceptible organisms
|